First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report

Zamiatina, V.I.; Magomedova, A.U.; Kravchenko, S.K.; Giliazitdinova, E.A.; Iliushkina, E.A.; Zvonkov, E.E.; Kaplanskaia, I.B.; Obukhova, T.N.; Kliasova, G.A.; Gorgidze, L.A.; Churakova, Z.V.; Kremenetskaia, A.M.; Vorob'ev, A.I.; Zamiatina, V.I; Magomedova, A.U; Kravchenko, S.K; Giliazitdinova, E.A; Iliushkina, E.A; Zvonkov, E.E; Kaplanskaia, I.B; Obukhova, T.N; Kliasova, G.A; Gorgidze, L.A; Churakova, Z.V; Kremenetskaia, A.M; Vorob&apo; ev, A.I

Home

>

Node

>

Subnode

First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report

Zamiatina, V.I.; Magomedova, A.U.; Kravchenko, S.K.; Giliazitdinova, E.A.; Iliushkina, E.A.; Zvonkov, E.E.; Kaplanskaia, I.B.; Obukhova, T.N.; Kliasova, G.A.; Gorgidze, L.A.; Churakova, Z.V.; Kremenetskaia, A.M.; Vorob'ev, A.I.

Terapevticheskii Arkhiv 81(7): 71-75

2009

ISSN/ISBN: 0040-3660

PMID: 19708578

Document Number: 632003

Primary skin large B-cell lymphosarcomas (PLBCL) present with skin lesions, other organs and systems are not involved. As CHOP courses are not high effective in PLBCL, we were the first to treat a patient with modified block therapy NHL BFM-90. A complete remission was achieved after the first course of polychemotherapy and was consolidated by two courses of treatment. Further follow-up is needed.